Cerebellar Stimulation and Cognitive Control
200
about 8 years
18–90
1 site in IA
What this study is about
This trial is testing if cerebellar stimulation can improve cognitive function and mood in people with schizophrenia, autism, bipolar disorder, Parkinson's disease, or depression. The treatment involves a device that delivers repetitive transcranial magnetic stimulation (rTMS).
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Repetitive Transcranial Magnetic Stimulation (rTMS)
- 2.Use Sham Repetitive Transcranial Magnetic Stimulation (rTMS)
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Change in disease-specific symptom rating scale, one scale identified for each group (MADRS for bipolar group; PANSS for schizophrenia group; UPDRS in Parkinson's patient group).
Secondary: Change in PHQ9 score., Change in cognitive function, Changes in MRI-based timing task., Changes in T1 rho MRI signal., Changes in functional MRI, Changes in structural MRI., Schizophrenia group: Change in Calgary depression scale.
therapeutic
Neurology, Psychiatry / Mental Health